As cancer cases surge globally, world leaders have come together to reaffirm their commitment to intensifying efforts against this devastating disease. At a meeting on 16 June 2026, the G7 nations, along with partner countries Brazil, Egypt, India, Kenya, and South Korea, pledged to work more closely together in the fight against cancer. The joint statement highlights the alarming growth of cancer cases worldwide and outlines strategies for a co-ordinated international response.
Cancer claims nearly 10 million lives globally each year, a figure that is expected to rise significantly. Experts predict an 80% increase in new cases by 2050, mainly due to an ageing global population and its impact on environmental and behavioural risk factors. This rapid growth will put immense pressure on healthcare systems, national economies, and societies worldwide.
The G7 leaders stressed the urgent need for improved access to cancer prevention, including enhanced screening programmes, more accurate diagnosis, and advanced care pathways. While acknowledging significant progress in oncology research, they called for accelerated efforts through better alignment of research and faster translation of innovative discoveries into practical patient care. A key focus is the acceleration of efforts towards eliminating cervical cancer, which is now considered within reach due to recent scientific breakthroughs.
International cooperation in cancer research will be deepened, with a particular emphasis on addressing persistent gaps in early detection and prevention. The leaders pledged to ensure that progress in oncology benefits every patient, acknowledging existing financial contributions and shared global responsibility. They committed to strengthening endeavours in cancer research and development, including building on concrete progress already made, such as aligning cancer research programmes and fostering collaboration between leading cancer institutes.
The declaration specifically addresses the challenge of cancers with poor prognosis, recognising them as a major global scientific hurdle. The G7 intends to support research in this area, work towards a shared international definition and research agenda, and set ambitious targets for screening programmes. A particular goal is to significantly reduce lung cancer mortality within the next decade by diagnosing more cases at Stage 1. Furthermore, the initiative seeks to foster innovative international research programmes and enhance cooperation on clinical trials.
Another crucial element of the strategy is accelerating international data access for paediatric, adolescent, and young adult cancers. The leaders acknowledge that no single country possesses sufficient data to generate robust evidence across the full spectrum of these tumour types. They intend to promote collaboration between existing data resources, bridge national registries, and advance interoperability standards.